Delivery Order SPE2DB20D2001-SPE2DB25FPNST
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,063.72 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 mcg inhaler in 8.5 gram units. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office is headquartered. As a non-set-aside contract, this award was made through open...
- The Defense Logistics Agency awarded a delivery order valued at $1,177.63 to AmerisourceBergen Drug Corp for Albuterol HFA 90 mcg inhaler 8.5 gm, with an ultimate completion date of September 11, 2025. This competitive award uses firm fixed pricing with no set-aside designation and is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader supply relationship with the federal government for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, valued at $1,665.03. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, with a completion deadline of September 9, 2025. The award represents a continuation of AmerisourceBergen's substantial role in federal pharmaceutical procurement, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams) with a ceiling value of $4,328.64. This firm fixed-price delivery order represents a non-competitive set-aside and is scheduled for completion by August 18, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,292.72 to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG Inhaler 8.5GM, a commonly prescribed bronchodilator medication used to treat asthma and chronic obstructive pulmonary disease. This non-set-aside contract was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, and operates under firm fixed pricing terms. The place of performance is listed as Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams) at a ceiling value of $1,585.92. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a direct procurement under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. No set-aside designation was applied to this award, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $1,400.36 to AmerisourceBergen Drug Corp for Albuterol HFA 90 mcg inhalers (8.5 grams) on August 25, 2025, with completion scheduled for August 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,773.92 to AmerisourceBergen Drug Corp for Albuterol HFA 90 micrograms inhalers (8.5 grams) on July 17, 2025, with an ultimate completion date of July 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,658.88 to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG Inhaler 8.5GM on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed price, competitively awarded delivery order carries no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply delivery under the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Albuterol HFA 90 MCG Inhaler in 8.5GM units, valued at $1,518.96. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNSTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,588.48 to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG Inhaler 8.5GM, a commonly prescribed bronchodilator medication used in respiratory treatment. The award, issued on September 15, 2025, with completion targeted for September 16, 2025, was structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle for military and federal healthcare systems, enabling the company to provide a broad range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal customers globally. AmerisourceBergen's established presence as a pharmaceutical prime vendor demonstrates its capacity to fulfill critical medical supply requirements for federal defense and healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/15/25 |